Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 870Neoplasms 657Prostatic Neoplasms 448Lung Neoplasms 361Colorectal Neoplasms 333Carcinoma, Non-Small-Cell Lung 324Leukemia, Myeloid, Acute 256Pancreatic Neoplasms 222Brain Neoplasms 204Multiple Myeloma 202Neoplasm Metastasis 198Carcinoma, Hepatocellular 182Head and Neck Neoplasms 178Glioblastoma 169Precursor Cell Lymphoblastic Leukemia-Lymphoma 167Melanoma 156Ovarian Neoplasms 151Squamous Cell Carcinoma of Head and Neck 150Rectal Neoplasms 135Recurrence 133Hematologic Neoplasms 127Sarcoma 125Uterine Cervical Neoplasms 124Stomach Neoplasms 118Glioma 117Triple Negative Breast Neoplasms 116Carcinoma, Renal Cell 116Motor Activity 101Urinary Bladder Neoplasms 99Colonic Neoplasms 99

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Scleroderma, Systemic × 90 days × Clear all
NCT07085676 2026-05-06

Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases

Hadassah Medical Organization

Phase 1 Recruiting
120 enrolled

Arthritis, Rheumatoid, Lupus Erythematosus, Systemic, Multiple Sclerosis, Myasthenia Gravis, Myositis, Neuromyelitis Optica, Scleroderma, Systemic, Antiphospholipid Syndrome, Multiple Sclerosis, Chronic Progressive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡